Botulinum Toxin in the Treatment of Facial Paralysis

Facial Plastic Surgery Clinics of North America

Volumn 24, Issue 1, 2016, Pages 11-20

  Mehdizadeh, Omid B ^a   Diels, Jacqueline ^b   White, William Matthew ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b University of Wisconsin Health   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Asymmetry; Botulinum toxin; Facial paralysis; Synkinesis

Indexed keywords

BOTULINUM TOXIN;

DENERVATION; EXERCISE; FACE ASYMMETRY; FACIAL NERVE PARALYSIS; HUMAN; MEDICAL ASSESSMENT; MUSCLE RELAXATION; NECK; NEUROLYSIS; NEUROMUSCULAR FACILITATION; NEUROMUSCULAR RETRAINING; OUTCOME ASSESSMENT; REVIEW; SYNKINESIS; FACIAL PARALYSIS; FEMALE; MALE;

BOTULINUM TOXINS; FACIAL PARALYSIS; FEMALE; HUMANS; MALE;

EID: 84961837692     PISSN: 10647406     EISSN: 15581926     Source Type: Journal    
DOI: 10.1016/j.fsc.2015.09.008     Document Type: Review

References (40)

1. Guerrissi J.O. Selective myectomy for postparetic facial synkinesis. Plast Reconstr Surg 1991, 87:459-466.
2. Chen C.-K., Tang Y.-B. Myectomy and botulinum toxin for paralysis of the marginal mandibular branch of the facial nerve: a series of 76 cases. Plast Reconstr Surg 2007, 120(7):1859-1864.
3. Terzis J.K., Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients. J Plast Reconstr Aesthet Surg 2012, 65(8):1009-1018.
4. Chuang D.C., Chang T.N., Lu J.C. Postparalysis facial sykinesis: clinical classification and surgical strategies. Plast Reconstr Surg Glob Open 2015, 3:e320.
5. Haykal S., Arad E., Bagher S., et al. The role of Botulinum Toxin A in the establishment of symmetry in pediatric analysis of the lower lip. JAMA Facial Plast Surg 2015, 17(3):174-178.
6. Azuma T., Nakamura K., Takahashi M., et al. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Otolaryngol Head Neck Surg 2012, 146:40-45.
7. Lee J.M., Choi K.H., Lim B.W., et al. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis. J Plast Reconstr Aesthet Surg 2015, 68(1):71-78.
8. Chen J.J., Dashtipour K. Abo-, inco-, ona-, and rimabotulinum toxins in clinical therapy: a primer. Pharmacotherapy 2013, 33(3):304-318.
9. Toffola E.D., Furini F., Redaelli C., et al. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 2010, 32(17):1414-1418.
10. Armstrong M.W., Mountain R.E., Murray J.A. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci 1996, 21(1):15-20.
11. Couch S.M., Chundury R.V., Holds J.B. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthal Plast Reconstr Surg 2014, 30(3):246-250.
12. Borodic G.E., Pearce L.B., Cheney M., et al. Botulinum A toxin for treatment of aberrant facial nerve regeneration. Plast Reconstr Surg 1993, 91:1042-1045.
13. Scott A.B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980, 87:1044-1049.
14. Carruthers J.D., Carruthers J.A. Treatment of glabellar frown lines with C. Botulinum A exotoxin. J Dermatol Surg Oncol 1992, 18:17-21.
15. Borodic G., Bartley M., Slattery W., et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo controlled trial using subjective endpoints. Plast Reconstr Surg 2005, 116(1):36-43.
16. Mehta R.P., Hadlock T. Botulinum toxin and quality of life in patients with facial paralysis. Arch Facial Plast Surg 2014, 10(2):84-87.
17. Ross B.G., Fradet G., Nedzelski J.M. Development of a sensitive clinical facial grading system. Eur Arch Otorhinolaryngol 1994, S180-S181.
18. Mehta R.P., WernickRobinson M., Hadlock T.A. Validation of the synkinesis assessment questionnaire. Laryngoscope 2007, 117(5):923-926.
19. Filipo R., Spahiu I., Covelli E., et al. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope 2012, 122:266-270.
20. Putterman A.M. Botulinum toxin injections in the treatment of seventh nerve misdirection. Am J Ophthalmol 1990, 110:205-206.
21. Chua C.N., Quhill F., Jones E., et al. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit 2004, 23(4):213-218.
22. Rogers C.R., Schmidt K.L., VanSwearingen J.M., et al. Automated facial image analysis: detecting improvement in abnormal facial movement after treatment with botulinum toxin A. Ann Plast Surg 2007, 58(1):39-47.
23. de Maio M., Bento R.F. Botulinum toxin in facial palsy: an effective treatment for contralateral hyperkinesis. Plast Reconstr Surg 2007, 120(4):917-927.
24. Salles A.G., Toledo P.N., Ferreira M.C. Botulinum toxin injection in long standing facial paralysis patients: improvement of facial symmetry observed up to 6 months. Aesthetic Plast Surg 2009, 33(4):582-590.
25. Kollewe K., Mohammadi B., Dengler R., et al. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. J Neural Transm 2010, 117(6):759-763.
26. Monini S., De Carlo A., Biagini M., et al. Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol 2011, 131(8):882-886.
27. Sadiq S., Khwaja S., Saeed S. Botulinum toxin to improve lower facial symmetry in facial nerve palsy. Eye 2012, 73(11):1431-1436.
28. McElhinny E.R., Reich I., Burt B., et al. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A. Ophthal Plast Reconstr Surg 2013, 29(3):175-178.
29. Choi K.H., Rho S.H., Lee J.M., et al. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthet Surg 2013, 66(8):1058-1063.
30. Montserrat L., Benito M., Jankovic J., et al. Facial synkinesis and aberrant regeneration of facial nerve. Advances in neurology: facial dyskinesias 1988, vol. 49:211-224. New York Raven Press.
31. Bacsi A.M., Kiernan M.C. Changes in axonal excitability and burst pattern behaviour in synkinesis. J Clin Neurosci 2008, 15(11):1288-1290.
32. Maeyama H., Aoyagi M., Tojima H., et al. Electrophysiological study on the pathology of synkinesis after facial nerve paralysis. Acta Otolaryngol Suppl 1994, 511:161-164.
33. Moran C.J., Neely J.G. Patterns of facial nerve synkinesis. Laryngoscope 1996, 106(12):1491-1496.
34. Basmajian J.V., DeLuca C.J. Muscles Alive: Their Functions Revealed by Electromyography 1985, Williams & Wilkins, Baltimore.
35. Diels H.J., Beurskens C. Neuromuscular Retraining: Non-Surgical Therapy for Facial Palsy. The Facial Nerve 2014, 205-212. Thieme, New York. W. Slattery, B. Azizzadeh (Eds.).
36. Balliet R., Shinn J.B., Bach-y-Rita P. Facial paralysis rehabilitation: retraining selective muscle control. Int Rehabil Med 1982, 4(2):67-74.
37. Wei L., Diels J., Lucarelli M. Treating buccinator with botulinum toxin in patients with facial synkinesis - a previously overlooked target. Ophthal Plast Re- constr Surg 2015, [Epub ahead of print].
38. Rubin L.R. The anatomy of a smile: its importance in the treatment of facial paralysis. Plast Reconstr Surg 1974, 53:384-387.
39. Brandt F., O'Connell C., Cazzaniga A., et al. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Derm Surg 2010, 36(S4):2111-2118.
40. Stone H.F., Zhu Z., Thach T., et al. Characterization of diffusion and duration of action of a new botulinum toxin type A formulation. Toxicon 2011, 58:159-167.